[AMRX] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[AMRX] Amneal Pharmaceuticals, Inc.
Announcement Date
07-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- 103.17%
YoY- -74.04%
Quarter Report
AMRX's Result
AMRX's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 404,642 446,120 497,528 476,487 413,787 275,189 293,369 23.98%
PBT -56,227 -133,180 -14,806 22,574 -262,506 52,016 62,075 -
Tax -5,701 -8,428 5,524 5,109 -12,416 364 -119 1228.45%
NP -16,902 -47,881 -8,768 6,952 -219,445 51,535 61,569 -
Tax Rate - - - -22.63% - -0.70% 0.19% -
Total Cost 421,544 494,001 506,296 469,535 633,232 223,654 231,800 49.15%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin -4.18 -10.73 -1.76 1.46 -53.03 18.73 20.99 -
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -0.13 -0.37 -0.07 0.05 -1.73 0.45 0.54 -
EPS Diluted -0.13 -0.37 -0.07 0.05 -1.73 0.45 0.54 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.